Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
US Army
QuintilesIMS
Teva
Daiichi Sankyo
Deloitte

Generated: September 23, 2019

DrugPatentWatch Database Preview

Patent: 7,265,216

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,265,216
Title:Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
Abstract: The present invention provides a transmembrane serine protease TADG-12 protein, splice variants of the TADG-12 protein and DNA fragments encoding such proteins. Also provided are vectors and host cells capable of expressing the DNAs. The present invention further provides various methods of early detection and therapies of associated ovarian and other malignancies by utilizing the DNAs and/or proteins disclosed herein.
Inventor(s): O\'Brien; Timothy J. (Little Rock, AR)
Assignee: The Board of Trustees of the University of Arkansas System (Little Rock, AR)
Application Number:10/357,175
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,265,216
Patent Claims:see list of patent claims

Details for Patent 7,265,216

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up The Board of Trustees of the University of Arkansas System (Little Rock, AR) 2020-03-02 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up The Board of Trustees of the University of Arkansas System (Little Rock, AR) 2020-03-02 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up The Board of Trustees of the University of Arkansas System (Little Rock, AR) 2020-03-02 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Teva
Express Scripts
McKesson
Fuji
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.